Course Description

The 2023 UCLA Advanced Lung Disease and Lung Transplantation Symposium is a hybrid virtual and in-person conference, organized by UCLA Health, the UCLA Office of Continuing Medical Education, and a multi-disciplinary group of speakers. The goal of the program

is to provide updated information on state-of-the-art therapies available for patients with end-stage lung disease, including medical and interventional approaches, as well as lung transplantation.

Target Audience

This conference is targeted at pulmonologists, cardiologists, critical care physicians, internists, cardiac and thoracic surgeons as well as allied health professionals who care for patients with advanced lung disease or refer patients for lung transplantation.

Learning Objectives

At the conclusion of the program participants will be able to:

• Identify when to refer patients for lung transplantation and gain an understanding of recent advances in the field that may allow patients who were previously not eligible for transplantation to be considered.

• Identify the importance of psychosocial support after lung transplantation.

• Recognize how health care disparities affect those with advanced lung disease.

• Be familiar with the diagnostic best practices when evaluating a patient with interstitial lung disease, including the use of multidisciplinary discussion.

• Implement current state-of-the-art diagnostic tools and treatment strategies in managing patient with sarcoidosis

• Gain a better understanding of the complex interaction between interstitial lung disease and pulmonary vascular disease.